US Patent Office Issues Patent for Oral Insulin Delivery

| Oct 26, 2013

The US Patent Office has issued a patent to Massachusetts-based Aphios Corporation for the oral delivery of insulin.

Patent No. 8,440,614, "Polymer Microspheres/Nanospheres and Encapsulating Therapeutic Proteins Therein," covers the design of an insulin delivery system that would eliminate the need for injections.

Calling an oral delivery system "one of the Holy Grails of biotechnology and drug development," Aphios says its patent gets around the greatest roadblock oral insulin developers have always faced: How to get insulin intact into the bloodstream before the digestive system's powerful enzymes can tear apart the hormone's delicate protein molecules.

The company's oral insulin product now under development, APH-0907, encapsulates insulin in biodegradable, hydrophobic polymer nanospheres. In layman's terms, hydrophobic polymers are tough, water-repellant materials whose molecular bonds are numerous and strong. Nanospheres are microscopic drug-bearing orbs made from the polymers.

The polymer, which is resistant to stomach acids, protects insulin from enzymatic degradation during its passage through the stomach. When nanoparticles reach the gut, they stick to the cell wall lining because of their ability to repel water and are then transported across the lining into the bloodstream. The nanoparticles are rapidly transported into the circulatory system, and as their biodegradable polymer shells degrade, their insulin cargo is released into the blood stream.

A patent is just a first step toward a workable oral insulin delivery system. However, taking the step to gain government recognition and protection of its approach to the problem says that Aphios is confident that it may have found the answer to an old problem.

The use of nanotechnology, which we touched on October 23 in article 8030 on this website ("Life With Type 2: Nano, Nano, as Mork Almost Said"), is unfolding as a major breakthrough in the treatment of disease. The ability to deliver drug doses via microscopic carriers to incredibly precise targets is opening up great new therapeutic possibilities for doctors and patients.

More information on the Aphios patent is available at

Click Here To View Or Post Comments

Categories: APH-0907, Aphios Corporation, Hydrophobic Polymer Nanospheres, Nanoparticles, Oral Insulin Delivery

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated

Latest Hydrophobic Polymer Nanospheres Articles

Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.